All Articles on Vaccine

• 
  High-dose vaccine may protect seniors better

  Thanks to a new flu vaccine being distributed this flu season, seniors are getting more protection against serious seasonal flu viruses.
• 
  Why aren’t pregnant women getting flu vaccine?

  Why aren’t pregnant women getting flu vaccine?—Both mother and fetus are at increased risk for complications of flu infection during pregnancy. Prenatal care providers say they’re advising women to get the flu vaccine, but many pregnant women opt out.
• Vaccinations: A public health benefit

  Most parents choose to protect their children from diseases such as measles, meningitis, polio, and whooping cough through vaccinations. But a rising number opt not to vaccinate their children fully according to the recommended schedule, and many parents have concerns about the safety or necessity of vaccines.
• Delaying measles-related vaccines may raise seizure risk

  Delaying the first dose of the measles-mumps-rubella (MMR) and measles-mumps-rubella-varicella (MMRV) vaccines in children older than 15 months—outside the recommended schedule—may actually more than double the risk of fever-related seizures.
• Flu season never ends for Group Health researchers

  Although this year’s flu season is pretty typical, we’re seeing more hospitalizations of people under age 65 than normal, probably because H1N1 is the predominant virus and it affects younger people more than other flu strains.
• Epidemic of E. coli infections traced to one strain

  Virulent, drug-resistant forms of Escherichia coli that have recently spread around the world emerged from a single strain of the bacteria—not many different strains, as has been widely supposed, according to a new study in mBio, the flagship journal of the American Society for Microbiology. The strain causes millions of urinary, kidney, and bloodstream infections a year and has a far greater clinical and economic impact than any other strain of bacteria, including the so-called MRSA (methicillin-resistant Staphylococcus aureus) superbug.”
• NIH expands Vaccine and Treatment Evaluation Units

  A nationwide group of institutions that conducts clinical trials of promising candidate vaccines and therapies for infectious diseases, known as the Vaccine and Treatment Evaluation Units (VTEUs), has been awarded nine contracts to strengthen and broaden the scope of its research. Group Health Research Institute is one of these institutions.